Search

Addressing IOP and QOL With LAL, iStent, and Dextenza

I. Paul Singh, MD

Show Description +

I. Paul Singh, MD, discusses the current technologies available to maintain good quality of life (QOL) for patients while also aggressively managing IOP. In this case, the patient had a history of primary open-angle glaucoma and monovision. Dr. Singh demonstrates the implantation of an Light Adjustable Lens (LAL, RxSight) and iStent (Glaukos) with use of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Posted: 2/27/2023

Keywords:

Light Adjustable Lens

•

RxSight

•

iStent

•

Dextenza

Up Next

Management of Dislocated Posterior Chamber IOL

Management of Dislocated Posterior Chamber IOL

Altan A. Ozcan, MD

Posterior Lamellar Keratoplasty and Dislocated IOL

Posterior Lamellar Keratoplasty and Dislocated IOL

Ozana Moraru, MD

Scleral Fixation of Dislocated IOL Complex

Scleral Fixation of Dislocated IOL Complex

Majid Moshirfar, MD

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

PXF Dislocated IOL, IOL Exchange with Gortex Sutured IOL

Michael Patterson, DO

Refixation of a Dislocated Gortex Sutured Akreos IOL

Refixation of a Dislocated Gortex Sutured Akreos IOL

Jason N. Crosson, MD, Michael A. Albert MD

Dislocated IOL to Glued IOL

Dislocated IOL to Glued IOL

Michael Patterson, DO

Bubble Bubble Toil and Trouble

Bubble Bubble Toil and Trouble

Jason Jones, MD

Phacoemulsification Hard Cataract With Lens Coloboma

Phacoemulsification Hard Cataract With Lens Coloboma

Maneesh Bapaye, MD

Phaco Debulk Chop for Dense Cataracts

Phaco Debulk Chop for Dense Cataracts

Iqbal "Ike" K. Ahmed, MD, FRCSC

My Technique for Modern ECCE

My Technique for Modern ECCE

Ashraf Armia, MD

Addressing IOP and QOL With LAL, iStent, and Dextenza

I. Paul Singh, MD

I. Paul Singh, MD, discusses the current technologies available to maintain good quality of life (QOL) for patients while also aggressively managing IOP. In this case, the patient had a history of primary open-angle glaucoma and monovision. Dr. Singh demonstrates the implantation of an Light Adjustable Lens (LAL, RxSight) and iStent (Glaukos) with use of Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix).

Posted: 2/27/2023

Keywords:

Light Adjustable Lens

•

RxSight

•

iStent

•

Dextenza

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD